ghk-cu injection results timeline Peptide Before and After: What Changes Can You Expect? This peptide reverses aging..., And

Studies suggest 10-20 times higher tissue concentrations compared to topical application of equivalent amounts

The exact temporal coincidence of changes in follicle size, cutaneous (but not epidermal) thickness, and perifollicular vascularization suggested that the angiogenic stimulus was derived from either the hair follicle itself or the surrounding dermis and subcutis, but not from the interfollicular epidermis

It may be slightly less stable than GHK-Cu due to differences in copper binding affinity, which makes proper formulation and storage even more important

lowest tolerated dose Phase Step 2 Weeks Weeks 5-8 Cagrilintide Dose 0.5 mg/week Purpose Dose escalation Phase Step 3 Weeks Weeks 9-12 Cagrilintide Dose 1.0 mg/week Purpose GI side effects often peak here Phase Step 4 Weeks Weeks 13-16 Cagrilintide Dose 1.7 mg/week Purpose Approaching maintenance Phase Maintenance Weeks Weeks 17+ Cagrilintide Dose 2.4 mg/week Purpose Target dose used in late-stage study protocols Each step lasts 4 weeks

Biochemistry, peptide